Related Experiment Video
Updated: Aug 13, 2026
11:25
Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice
Published on: April 1, 2015
Mixed chimaerism; detection and significance following BMT
1Department of Haematology and Genetics, St James Hospital, Dublin, Ireland.
Bone Marrow Transplantation
|February 1, 1993
Summary
Mixed chimaerism, the coexistence of recipient and donor cells after bone marrow transplantation (BMT), can be detected using sensitive DNA methods. Its impact on leukemia relapse and graft rejection remains uncertain, potentially varying by cell lineage.
Area of Science:
- Hematology
- Transplantation immunology
Background:
- Mixed chimaerism occurs when residual recipient hematopoietic cells coexist with donor hematopoietic tissue post-bone marrow transplantation (BMT).
- The detection sensitivity of chimaerism varies, with DNA-based methods offering the highest sensitivity.
Purpose of the Study:
- To investigate the unclear influence of mixed chimaerism on leukemia relapse and graft rejection.
- To explore how the specific cell lineages involved in mixed chimaerism might affect patient outcomes.
Main Methods:
- Utilized sensitive DNA-based methodologies for detecting mixed chimaerism.
- Analyzed the incidence of mixed chimaerism in patients undergoing BMT.
Main Results:
- Mixed chimaerism incidence is dependent on the detection system's sensitivity.
- The specific hematopoietic lineages exhibiting mixed chimaerism were considered in relation to outcomes.
Conclusions:
- The clinical significance of mixed chimaerism, particularly its effect on leukemia relapse and graft rejection, requires further elucidation.
- The lineage distribution of mixed chimaerism may be a critical factor influencing transplant outcomes.
